Nov 26, 2019: Healx’s Applications are now being accepted for its Rare Treatment Accelerator (RTA), new programme that focus on finding new treatments for rare diseases.
The AI-powered and patient-inspired technology company sponsors the project with a total of $20m funding injection, contemplate to invest up to $1m of that in AI and drug discovery resources per disease project.
- Advertisement -
The collaboration offers rare disease patient groups and clinicians the prospect to work with Healx to reveal new treatments for rare disease, combining their data, AI capabilities and disease proficiency to discover new treatments and move them towards the clinic within 24 months.
https://healx.io/news/
